These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 28478637)

  • 1. Effects of fecal sampling on preanalytical and analytical phases in quantitative fecal immunochemical tests for hemoglobin.
    Rapi S; Berardi M; Cellai F; Ciattini S; Chelazzi L; Ognibene A; Rubeca T
    Int J Biol Markers; 2017 Jul; 32(3):e261-e266. PubMed ID: 28478637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A proposal to standardize reporting units for fecal immunochemical tests for hemoglobin.
    Fraser CG; Allison JE; Halloran SP; Young GP;
    J Natl Cancer Inst; 2012 Jun; 104(11):810-4. PubMed ID: 22472305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does the mass of sample loaded affect faecal haemoglobin concentration using the faecal immunochemical test?
    Piggott C; John C; Bruce H; Benton SC
    Ann Clin Biochem; 2018 Nov; 55(6):702-705. PubMed ID: 29792043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of preanalytical factors on fecal immunochemical tests: need for new strategies in comparison of methods.
    Rubeca T; Cellai F; Confortini M; Fraser CG; Rapi S
    Int J Biol Markers; 2015 Jul; 30(3):e269-74. PubMed ID: 26044774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Temperature and Time on Fecal Hemoglobin Stability in 5 Fecal Immunochemical Test Methods and One Guaiac Method.
    Catomeris P; Baxter NN; Boss SC; Paszat LF; Rabeneck L; Randell E; Serenity ML; Sutradhar R; Tinmouth J
    Arch Pathol Lab Med; 2018 Jan; 142(1):75-82. PubMed ID: 28967803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender Differences in Fecal Immunochemical Test Performance for Early Detection of Colorectal Neoplasia.
    Kapidzic A; van der Meulen MP; Hol L; van Roon AH; Looman CW; Lansdorp-Vogelaar I; van Ballegooijen M; van Vuuren AJ; Reijerink JC; van Leerdam ME; Kuipers EJ
    Clin Gastroenterol Hepatol; 2015 Aug; 13(8):1464-71.e4. PubMed ID: 25724706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to improve the performances of Fecal Immunological Tests (FIT): Need for standardization of the sampling and pre-analytical phases and revision of the procedures for comparison of methods.
    Rapi S; Rubeca T; Fraser CG
    Int J Biol Markers; 2015 Feb; 30(1):e127-31. PubMed ID: 24855037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of a new sampling buffer on faecal haemoglobin stability in a colorectal cancer screening programme by the faecal immunochemical test.
    Grazzini G; Ventura L; Rubeca T; Rapi S; Cellai F; Di Dia PP; Mallardi B; Mantellini P; Zappa M; Castiglione G
    Eur J Cancer Prev; 2017 Jul; 26(4):285-291. PubMed ID: 27271031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel artificial stool material for external quality assurance (EQA) on a fecal immunochemical test for hemoglobin (FIT): The confirmed utility of stable hemoglobin and an internal standard material.
    Yasui R; Yamada M; Takehara S; Sakurabayashi I; Watanabe K
    Clin Chim Acta; 2018 Aug; 483():76-81. PubMed ID: 29673583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are fecal immunochemical test characteristics influenced by sample return time? A population-based colorectal cancer screening trial.
    van Roon AH; Hol L; van Vuuren AJ; Francke J; Ouwendijk M; Heijens A; Nagtzaam N; Reijerink JC; van der Togt AC; van Ballegooijen M; Kuipers EJ; van Leerdam ME
    Am J Gastroenterol; 2012 Jan; 107(1):99-107. PubMed ID: 22108450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic yield improves with collection of 2 samples in fecal immunochemical test screening without affecting attendance.
    van Roon AH; Wilschut JA; Hol L; van Ballegooijen M; Reijerink JC; 't Mannetje H; Kranenburg LJ; Biermann K; van Vuuren AJ; Francke J; van der Togt AC; Habbema DJ; van Leerdam ME; Kuipers EJ
    Clin Gastroenterol Hepatol; 2011 Apr; 9(4):333-9. PubMed ID: 21185397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effect of the Variability in Fecal Immunochemical Test Sample Collection Technique on Clinical Performance.
    Symonds EL; Fraser CG; Bastin D; Berwald G; Young GP
    Cancer Epidemiol Biomarkers Prev; 2021 Jan; 30(1):175-181. PubMed ID: 33046449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia.
    Smith A; Young GP; Cole SR; Bampton P
    Cancer; 2006 Nov; 107(9):2152-9. PubMed ID: 16998938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colorectal cancer detection in an asymptomatic population: fecal immunochemical test for hemoglobin vs. fecal M2-type pyruvate kinase.
    Caviglia GP; Cabianca L; Fagoonee S; Gili FM
    Biochem Med (Zagreb); 2016; 26(1):114-20. PubMed ID: 26981025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk stratification for advanced colorectal neoplasia according to fecal hemoglobin concentration in a colorectal cancer screening program.
    Auge JM; Pellise M; Escudero JM; Hernandez C; Andreu M; Grau J; Buron A; López-Cerón M; Bessa X; Serradesanferm A; Piracés M; Macià F; Guayta R; Filella X; Molina R; Jimenez W; Castells A;
    Gastroenterology; 2014 Sep; 147(3):628-636.e1. PubMed ID: 24937264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Difference in performance of fecal immunochemical tests with the same hemoglobin cutoff concentration in a nationwide colorectal cancer screening program.
    Chiang TH; Chuang SL; Chen SL; Chiu HM; Yen AM; Chiu SY; Fann JC; Chou CK; Lee YC; Wu MS; Chen HH
    Gastroenterology; 2014 Dec; 147(6):1317-26. PubMed ID: 25200099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of delay in sampling on haemoglobin determined by faecal immunochemical tests.
    Brown LF; Fraser CG
    Ann Clin Biochem; 2008 Nov; 45(Pt 6):604-5. PubMed ID: 18782817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Setting up a service for a faecal immunochemical test for haemoglobin (FIT): a review of considerations, challenges and constraints.
    Godber IM; Benton SC; Fraser CG
    J Clin Pathol; 2018 Dec; 71(12):1041-1045. PubMed ID: 30275098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The fecal hemoglobin concentration, age and sex test score: Development and external validation of a simple prediction tool for colorectal cancer detection in symptomatic patients.
    Cubiella J; Digby J; Rodríguez-Alonso L; Vega P; Salve M; Díaz-Ondina M; Strachan JA; Mowat C; McDonald PJ; Carey FA; Godber IM; Younes HB; Rodriguez-Moranta F; Quintero E; Álvarez-Sánchez V; Fernández-Bañares F; Boadas J; Campo R; Bujanda L; Garayoa A; Ferrandez Á; Piñol V; Rodríguez-Alcalde D; Guardiola J; Steele RJ; Fraser CG;
    Int J Cancer; 2017 May; 140(10):2201-2211. PubMed ID: 28187494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance characteristics and evaluation of an automated-developed and quantitative, immunochemical, fecal occult blood screening test.
    Vilkin A; Rozen P; Levi Z; Waked A; Maoz E; Birkenfeld S; Niv Y
    Am J Gastroenterol; 2005 Nov; 100(11):2519-25. PubMed ID: 16279909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.